Condition
Enterovirus Infection
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
P 1 (3)
P 2 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06444048Phase 1CompletedPrimary
Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults
NCT02961595Phase 1CompletedPrimary
Live Enterovirus Vaccine and Type 1 Diabetes
NCT00031512Phase 2CompletedPrimary
Pleconaril Enteroviral Sepsis Syndrome
NCT01268787Phase 1CompletedPrimary
A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine
Showing all 4 trials